Prospective study of efficacy of negative pressure wound therapy for surgical site infection after hepatobiliary and pancreatic surgery

Prospective study of efficacy of negative pressure wound therapy for surgical site infection after hepatobiliary and pancreatic surgery - Prospective study of efficacy of negative pressure wound therapy for surgical site infection after hepatobiliary and pancreatic surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018054

Enrollment

Registered

2015-06-25

Start date

2015-06-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical site infection

Interventions

For the patients with surgical site infection after hepatobiliary and pancreatic surgery, unroofing and debridement of infected wound is performed. Therefore, negative pressure wound therapy is starte

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, The patients with surgical site infection after hepatobiliary and pancreatic surgery 2, Older than 20 years old 3, ECOG performance status of 0 to 2 4, Estimated survival is over 6 months 5, Documented informed consent

Exclusion criteria

Exclusion criteria: 1, Naked blood vessel suspected of bleeding or surgical site infection to directly contact to other organs or the presence of fistula to abdominal cavity. 2, The presence of organ/space surgical site infection 3, As determined by the principal investigator or the sub-investigator the subject is not adequate to participate in the study.

Design outcomes

Primary

Measure	Time frame
The duration from incidence of surgical site infection to wound healing	—

Secondary

Measure	Time frame
The postoperative hospital stay, the cost of hospitalization, the presence of reopened wound, the presence and degree of adverse events	—

Countries

Japan

Contacts

Public ContactTakehiro Noda

Osaka University, Graduate School of Medicine Department of Gastroenterological Surgery

tnoda@gesurg.med.osaka-u.ac.jp+81-6-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026